Management of chronic anal fissure: effectiveness of a personalized target-to-treat treatment algorithm

January 28, 2026
30
УДК:  616.351
Specialities :
Resume

Chronic anal fissure (CAF) is a common condition with a complex pathogenesis, the main element of which is a persistent increase in the tone of the internal anal sphincter. This forms a «pain — spasm — ischemia» cycle, leading to chronicity and resistance to standard approaches. In real clinical practice, the lack of a clear algorithm for selecting and escalating therapy often leads to premature surgical intervention or excessively long use of ineffective conservative methods. Objective: to evaluate the efficacy and safety of a personalized target-to-treat algorithm for the management of chroni­c anal fissure compared to standard tactics in a Ukrainian proctology center. Materials and methods. A single-center prospective comparative study was conducted. The main group (n=83) included patients who received treatment according to a personalized algorithm developed based on ASCRS and ACPGBI recommendations, with an individual choice of the first-line therapy (conservative therapy, botulinum toxin therapy, tailored lateral internal sphincterotomy, fissurectomy). The comparison group (n=72) consisted of patients treated according to the center’s standard protocol. The frequency of clinical healing, dynamics of pain syndrome (Visual Analogue Scale), quality of life indicators (SF-36), duration of disability, and the frequency of recurrences over 6 months were evaluated. Results. In the target-to-treat group, clinical healing was achieved in 92.1% (76/83) of patients, which was significantly higher than in the standard treatment group (71.8%, 52/72; p=0.015). The algorithm provided faster pain relief: the average time to reduce pain intensity by ≥50% on the Visual Analogue Scale was 5.8±2.1 days compared to 10.6±3.0 days in the control group (p<0.001). Quality of life indicators on the SF-36 scale improved significantly more in the main group across all domains (p<0.05). The duration of disability was lower (8.1±2.9 days vs. 14.7±4.1 days; p<0.001), and the recurrence rate after 6 months was significantly lower (7.23% vs. 22.22%; p=0.012). Conclusions. The personalized target-to-treat algorithm for the management of chronic anal fissure is a highly effective and safe approach. It provides a significantly higher rate of clinical healing, accelerates the regression of pain syndrome, improves quality of life, shortens the period of disability, and reduces the risk of recurrence compared to standard tactics. The algorithm can be recommended for widespread implementation in proctological practice.

References

  • 1. Newman M., Collie M. (2019) Anal fissure: diagnosis, management, and referral in primary care. Br. J. Gen. Pract., 69: 409–410. doi.org/10.3399/bjgp19X704957.
  • 2. Salati S.A. (2021) Anal Fissure — an extensive update. Pol. Przegl. Chir., 93: 46–56. doi.org/10.5604/01.3001.0014.7879.
  • 3. Higuero T. (2015) Update on the management of anal fissure. J. Visc. Surg., 152: S37–S43. doi.org/10.1016/j.jviscsurg.2014.07.007.
  • 4. Davids J.S., Hawkins A.T., Bhama A.R. et al. (2023) The American society of colon and rectal surgeons clinical practice guidelines for the management of anal fissures. Dis. Colon Rectum, 66: 190–199. doi.org/10.1097/DCR.0000000000002664.
  • 5. Cross K.L.R., Brown S.R., Kleijnen J. et al. (2023) The Association of Coloproctology of Great Britain and Ireland guideline on the management of anal fissure. Colorectal. Dis., 25: 2423–2457. doi.org/10.1111/codi.16762.
  • 6. Akinmoladun O., Oh W. (2024) Management of hemorrhoids and anal fissures. Surg. Clin. North Am., 104: 473–490. doi.org/10.1016/j.suc.2023.11.001.
  • 7. Brillantino A., Renzi A., Talento P. et al. (2023) The Italian Unitary Society of Colon-proctology (SIUCP: Società Italiana Unitaria di Colonproctologia) guidelines for the management of anal fissure. BMC Surg., 23: 311. doi.org/10.1186/s12893-023-02223-z.
  • 8. Boland P.A., Kelly M.E., Donlon N.E. et al. (2020) Management options for chronic anal fissure: a systematic review of randomised controlled trials. Int. J. Colorectal. Dis., 35: 1807–1815. doi.org/10.1007/s00384-020-03699-4.
  • 9. van Reijn-Baggen D.A., Dekker L., Elzevier H.W. et al. (2022) Management of chronic anal fissure: results of a national survey among gastrointestinal surgeons in the Netherlands. Int. J. Colorectal. Dis., 37: 973–978. doi.org/10.1007/s00384-022-04115-9.
  • 10. Asefa Z., Awedew A.F. (2023) Comparing closed versus open lateral internal sphincterotomy for management of chronic anal fissure: systematic review and meta-analysis of randomised control trials. Sci. Rep., 13: 20957. doi.org/10.1038/s41598-023-48286-z.
  • 11. Picciariello A., Tutino R., Gallo G. et al. (2024) Temporal trends and treatment patterns in anal fissure management: insights from a multicenter study in Italy. Tech. Coloproctol., 28: 139. doi.org/10.1007/s10151-024-03011-4.
  • 12. Roelandt P., Bislenghi G., Coremans G. et al. (2024) Belgian consensus guideline on the management of anal fissures. Acta Gastroenterol. Belg., 87: 304–321. doi.org/10.51821/87.2.11787.
  • 13. Wang C., Ni J., Xiong Y. et al. (2025) The efficacy of diltiazem, glyceryl trinitrate, nifedipine, minoxidil, and lidocaine for the medical management of anal fissure: a systematic review and network meta-analysis of randomized controlled trials. Int. J. Surg., 111: 3020–3029. doi.org/10.1097/JS9.0000000000002263.
  • 14. Sajid M.S., Whitehouse P.A., Sains P., Baig M.K. (2013) Systematic review of the use of topical diltiazem compared with glyceryltrinitrate for the nonoperative management of chronic anal fissure: Diltiazem and glyceryltrinitrate in chronic anal fissure. Colorectal. Dis., 15: 19–26. doi.org/10.1111/j.1463-1318.2012.03042.x.
  • 15. Motamed-Gorji N., Masoodi M., Sikaroudi M.K. et al. (2025) Exploring the therapeutic potential of L-arginine in chronic anal fissure management: a comprehensive review. Amino Acids, 57: 43. doi.org/10.1007/s00726-025-03478-x.
  • 16. Thippeswamy K.M., Gruber M., Abdelaziz H., Abdel-Dayem M. (2025) Efficacy and safety of botulinum toxin injection in the management of chronic symptomatic anal fissure: a systematic review and meta-analysis of randomized controlled trials. Tech. Coloproctol., 29: 44. doi.org/10.1007/s10151-024-03087-y.
  • 17. Abdiyeva G.K., Amirova M.F. (2025) Botulinum toxin injections vs lateral internal sphincterotomy in chronic anal fissure management. Afr. J. Reprod. Health, 29: 131–138. doi.org/10.29063/ajrh2025/v29i12.13.
  • 18. Essani R., Sarkisyan G., Beart R.W. et al. (2005) Cost-saving effect of treatment algorithm for chronic anal fissure: a prospective analysis. J. Gastrointest. Surg., 9: 1237–1243. doi.org/10.1016/j.gassur.2005.07.007.
  • 19. Christie A., Guest J.F. (2002) Modelling the economic impact of managing a chronic anal fissure with a proprietary formulation of nitroglycerin (Rectogesic) compared to lateral internal sphincterotomy in the United Kingdom. Int. J. Colorectal. Dis., 17: 259–267. doi.org/10.1007/s00384-001-0371-6.
  • 20. Brisinda G., Bianco G., Silvestrini N., Maria G. (2014) Cost considerations in the treatment of anal fissures. Expert Rev. Pharmacoecon. Outcomes Res., 14: 511–525. doi.org/10.1586/14737167.2014.924398.
  • 21. Key points from the evidence. NICE n.d. http://www.nice.org.uk/advice/esuom14/chapter/Key-points-from-the-evidence.
  • 22. Farkas N., Solanki K., Frampton A.E. et al. (2016) Are we following an algorithm for managing chronic anal fissure? A completed audit cycle. Ann. Med. Surg. (Lond.), 5: 38–44. doi.org/10.1016/j.amsu.2015.11.008.
  • 23. Nelson R.L., Thomas K., Morgan J., Jones A. (2012) Non surgical therapy for anal fissure. Cochrane Database Syst. Rev., 2012: CD003431. doi.org/10.1002/14651858.CD003431.pub3.
  • 24. Canero A., Consalvo V., Giglio F. et al. (2018) Conservative management of chronic anal fissure. Results of a case series at 2-years follow-up and proposition of a new classification. Surg. Technol. Int., 33: 105–109.
  • 25. Ram E., Zager Y., Meyer R. et al. (2023) Management of chronic anal fissure with a novel topical hemp-herbal-based ointment: A pilot study. Med. Cannabis Cannabinoids, 6: 15–20. doi.org/10.1159/000528119.
  • 26. Khan S.-Z.S., Martin S., Doh C.Y. et al. (2024) Trends in management of anal fissures. Am. Surg., 90: 393–398. doi.org/10.1177/00031348231200662.
  • 27. D’Orazio B., Geraci G., Di Vita G., Corbo G. (2021) Management of recurrent chronic anal fissure after lateral internal sphincterotomy. Asian J. Surg., 44: 932–933. doi.org/10.1016/j.asjsur.2021.03.054.
  • 28. Gallo G., Pegoraro V., Trompetto M. (2024) Description and management of patients with anal fissure: insights on Italian primary care setting coming from real-world data. Updates Surg., 76: 2193–2203. doi.org/10.1007/s13304-024-01882-8.
  • 29. Drezdzon M.K., Peterson C.Y. (2023) Anorectal emergencies. Surg. Clin. North Am., 103: 1153–1170. doi.org/10.1016/j.suc.2023.05.014.
  • 30. Wilson M.Z., Swarup A., Wilson L.R.T., Ivatury S.J. (2018) The effect of nonoperative management of chronic anal fissure and hemorrhoid disease on bowel function patient-reported outcomes. Dis. Colon Rectum, 61: 1223–1227. doi.org/10.1097/DCR.0000000000001193.
  • 31. Hwang S.H. (2022) Trends in treatment for hemorrhoids, fistula, and anal fissure: Go along the current trends. J. Anus Rectum. Colon, 6: 150–158. doi.org/10.23922/jarc.2022-012.
  • 32. Balla A., Saraceno F., Shalaby M. et al. (2023) Surgeons’ practice and preferences for the anal fissure treatment: results from an international survey. Updates Surg., 75: 2279–2290. doi.org/10.1007/s13304-023-01661-x.